{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T22:58:14Z","timestamp":1649113094553},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1989,6]]},"DOI":"10.1007\/bf00435846","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T09:58:10Z","timestamp":1100167090000},"page":"401-402","source":"Crossref","is-referenced-by-count":1,"title":["Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults"],"prefix":"10.1007","volume":"23","author":[{"given":"Sarah M.","family":"Donohue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Boughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","volume":"80","author":"RH Blum","year":"1974","unstructured":"Blum RH, Carter SK (1974) Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 80: 249","journal-title":"Ann Intern Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2141.1984.tb06099.x","volume":"58","author":"BJ Boughton","year":"1984","unstructured":"Boughton BJ, Franklin IM, Apperley J, Knight D (1984) Non-cardiotoxic anthracycline regimens in the treatment of acute myeloblastic leukaemia. Br J Haematol 58: 378","journal-title":"Br J Haematol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.7326\/0003-4819-88-2-168","volume":"88","author":"MR Bristow","year":"1978","unstructured":"Bristow MR, Mason JW, Billingham ME, Daniels JR (1978) Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy and cardiac catheterisation. Ann Intern Med 88: 168","journal-title":"Ann Intern Med"},{"issue":"1","key":"CR4","first-page":"47","volume":"64","author":"T Chlebowski","year":"1980","unstructured":"Chlebowski T, Paroly WS, Pugh RP, Hueser J, Jacobs EM, Pajak TF, Bateman JR (1980) Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity. Cancer Treat Rep 64 (1): 47","journal-title":"Cancer Treat Rep"},{"key":"CR5","series-title":"Clinics in haematology","volume-title":"Acute myeloid leukaemia. Recent advances in therapy","author":"RP Gale","year":"1986","unstructured":"Gale RP, Foon KA (1986) Acute myeloid leukaemia. Recent advances in therapy (Clinics in haematology, vol 15, no. 3, chap 10). W. B. Saunders, London"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-96-2-133","volume":"96","author":"SS Legha","year":"1982","unstructured":"Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein GR, Freidreich E (1982) Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96: 133","journal-title":"Ann Intern Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0305-7372(76)80018-7","volume":"3","author":"L Lenaz","year":"1976","unstructured":"Lenaz L, Page JA (1976) Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat Rev 3: 111","journal-title":"Cancer Treat Rev"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2141.1985.tb02824.x","volume":"61","author":"JP Lewis","year":"1985","unstructured":"Lewis JP, Meyers FJ, Tanaka L (1985) Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia. Br J Haematol 61: 261","journal-title":"Br J Haematol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(86)92674-7","volume":"ii","author":"JKH Rees","year":"1986","unstructured":"Rees JKH, Gray RG, Swirsky D, Hayhoe FGJ (1986) Principal results of the Medical Research Council's 8th Acute Myeloid Leukaemia Trial. Lancet ii: 1236","journal-title":"Lancet"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00435846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00435846\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00435846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T23:11:30Z","timestamp":1554851490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00435846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["BF00435846"],"URL":"https:\/\/doi.org\/10.1007\/bf00435846","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}